[Pharmacological basis of antineoplastic therapy].
D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000266:history / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use; D001215:Asparaginase / Q000627:therapeutic use; D003078:Colchicine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D049672:History, 19th Century; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D006918:Hydroxyurea / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D014118:Toxins, Biological / Q000627:therapeutic use; D014520:Urethane / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D001152:Arsenicals; D004967:Estrogens; D005493:Folic Acid Antagonists; D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D014118:Toxins, Biological; D003609:Dactinomycin; D014520:Urethane; D014750:Vincristine; D014747:Vinblastine; D015122:Mercaptopurine; D001215:Asparaginase; D003078:Colchicine; D005472:Fluorouracil; D006918:Hydroxyurea
Bases farmacológicas de la terapéutica antineoplástica.